Boddapati Kalyani Bhardwaj
Overview
Explore the profile of Boddapati Kalyani Bhardwaj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
19
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalyani Bhardwaj B, James A, Tomy J, K B S, Suresh P
J Biomol Struct Dyn
. 2024 Mar;
:1-12.
PMID: 38433426
Gambogic acid (GA), a xanthanoid compound, is derived from Garcinia Hanbury gamboge resin. Studying GA's DNA binding and targeting processes is crucial to understanding its tumor-targeting potentiality. This study used...
2.
Kalyani Bhardwaj B, Suresh P
Spectrochim Acta A Mol Biomol Spectrosc
. 2023 Oct;
306:123552.
PMID: 37883823
The objective of the current study was to synthesize, characterize and explore the interaction of PEGylated graphene oxide (pGO) and synthetic human Follicular stimulating hormone β 33-53 peptide conjugated PEGylated...
3.
Kalyani Bhardwaj B, Thankachan S, Magesh P, Venkatesh T, Tsutsumi R, Suresh P
Reprod Sci
. 2022 May;
30(2):335-349.
PMID: 35585292
Ovarian cancer is one of the leading causes of cancer-related deaths among women. The drawbacks of conventional therapeutic strategies encourage researchers to look for alternative strategies, including nanotechnology. Nanotechnology is...
4.
Thankachan S, Kalyani Bhardwaj B, Venkatesh T, Suresh P
Reprod Sci
. 2021 Feb;
28(9):2436-2447.
PMID: 33569749
Long non-coding RNAs (lncRNAs) are emerging regulators of cellular pathways, especially in cancer development. Among the lncRNAs, nuclear paraspeckle assembly transcript 1 (NEAT1) forms a scaffold for a nuclear body;...
5.
Kalyani Bhardwaj B, Thankachan S, Venkatesh T, Suresh P
Clin Chim Acta
. 2020 Jul;
510:28-34.
PMID: 32622965
Ovarian cancer is typically diagnosed at an advanced stage and poses a significant challenge to treatment and recovery. Relapsed ovarian cancer and chemoresistance of ovarian tumor cells are other clinical...